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ABSTRACT 
 
 
     Polycyclic aromatic hydrocarbons (PAHs) are hydrophobic organic compounds 
consisting of two or more fused benzene rings.  PAHs derive from many different sources 
including petroleum refining, wood treatment, and coal coking industries.  Because of 
their structural stability and water insolubility, PAHs are extremely resistant to 
degradation.  These compounds are also believed to have mutagenic, carcinogenic, and 
teratogenic effects.  Therefore, there are currently 16 PAH compounds on the EPA’s list 
of priority pollutants.   
     Many species of bacteria have the ability to breakdown these persistent pollutants.  
However, bioremediation strategies using these organisms have many unresolved issues.  
While laboratory experiments can easily demonstrate the ability of these organisms to 
breakdown pollutants, environmental factors may reduce degradation abilities in situ.    
     Within the prokaryotes, members of the genus Sphingomonas have demonstrated a 
greater ability to breakdown PAHs.  Spingomonas paucimobilis EPA505, for example, 
was shown to degrade a wide range of PAHs including the high molecular weight PAH 
fluoranthene, which it could also use as a sole carbon source.  Because of its potential as 
a bioremediation tool, it is important to study the molecular basis of PAH catabolism in 
EPA505.   
     A genomic library of EPA505 was constructed and probed for genes involved in PAH 
degradation.  Complete gene sequences were obtained for four subunits which are 
involved in the first step of the PAH catabolism.  This step is catalyzed by a dioxygenase 
enzyme and yields a dihydrodiol intermediate.  Two of the gene sequences encode an 
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alpha and beta subunit of the dioxygenase.  The third gene encodes a ferredoxin subunit 
and the fourth gene codes for a ferredoxin reductase subunit.   
     The four genes were cloned for expression.  Expression host cells were induced to test 
the activity of the four recombinant proteins on various PAHs.  When cells expressing all 
four subunits were incubated with naphthalene and phenanthrene, the corresponding 
dihydrodiol product was detected using GC-MS.  No dihydrodiol product was detected 
when fluoranthene was tested.  In addition, no dihydrodiol products were detected for any 
substrate when cells lacking the two ferredoxin subunits were tested.   
    This study identified and showed functional analysis of one enzyme, a PAH degrading 
dioxygenase in the PAH catabolic pathway of Sphingomonas paucimobilis EPA505.  
There is still much to learn in order to fully appreciate and take advantage of this 
organism as an efficient tool for bioremediation.   
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LITERATURE REVIEW 
 
1.1 Polycyclic Aromatic Hydrocarbons 
     Polycyclic aromatic hydrocarbons (PAHs) are hydrophobic organic compounds 
consisting of two or more fused benzene rings.  Ring arrangement can be linear, angular 
or clustered.  These compounds are generally classified into two categories based on size: 
1) low molecular weight (LMW) PAHs which contain two or three benzene rings and   2) 
high molecular weight (HMW) PAHs which contain four or more rings.  For example, 
naphthalene, phenanthrene and anthracene would be considered LMW PAHs whereas, 
fluoranthene, pyrene and chrysene would be considered HMW PAHs.   
     PAHs derive from many different sources including petroleum refining, wood 
treatment, and coal coking industries.  Other sources of PAHs can include gasoline and 
diesel fuel combustion, and tobacco smoke (1).  PAHs are ubiquitous pollutants which 
can contaminate water, vegetation and food.  These compounds and their derivatives can 
be found in the air, soil, surface water, groundwater and runoff.  Pollutant concentration 
varies widely throughout the environment ranging from 1µg/kg to over 300g/kg.  Factors 
that determine the amount of contamination include distance from the source, level of 
industrial development, and mode of transport for the pollutant (39). 
     The aromatic structures of PAHs make them chemically stable molecules.  They are 
water insoluble and form hydrophobic interactions with soil particles.  Because of their 
structural stability and water insolubility, PAHs are extremely resistant to degradation.  
They sorb strongly to soil particles and become inaccessible for degradation.  Larger 
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PAH molecules are more hydrophobic, and more resistant to degradation and therefore 
have a higher prevalence in the environment.  For example, phenanthrene, a three-ringed 
PAH, may have a half life of 16 to 126 days.  The half life of the five ringed PAH 
benzo[a]pyrene (Ba P), however, can range from 229 to 1,400 days (3).   
 
1.2 Health Risks 
     Health risks associated with PAHs have been well documented.  These compounds are 
thought to have mutagenic, carcinogenic, and teratogenic effects.  Because of these 
concerns, there are currently 16 PAH compounds on the EPA’s list of priority pollutants 
(Table 1.1) (4).   
     Kusk et al. (5) found a significant decrease in the photosynthetic activity of green 
algae that were exposed to PAHs.  PAHs have also caused digestive cell death in mussels 
(6), decreased reproductive rates in rainbow trout (7), and increased mortality rates in 
crustaceans (8).   
     With regard to mammalian studies, mice that were fed high levels of one PAH during 
pregnancy had difficulty reproducing as did their offspring. The offspring also had higher 
rates of birth defects and lower body weights (4). PAHs have caused lung cancer in 
laboratory animals that were exposed to contaminated air, stomach cancer when fed 
contaminated food, and skin cancer when PAHs were applied directly to the skin (4). 
     PAHs can contaminate vegetation through the soil and through runoff.  They can then 
be taken up by mammals through the digestive tract when contaminated food is ingested 
(9).  PAHs can even be transferred to humans through the consumption of seafood that 
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was caught in contaminated waters (10).   Because of the chemical nature of these 
compounds, they might associate with lipid components in biological tissues and interact 
with DNA to cause mutations in both prokaryotic and eukaryotic cells (11). 
     An example of the toxic effects of PAHs can be shown with naphthalene.  
Naphthalene binds to molecules in the liver, kidney and lung tissues and is known to 
inhibit mitochondrial respiration (12).  Phenanthrene, is known to be a photosensitizer of 
human skin and is also mutagenic to bacteria (13).  These are examples of some of the 
effects of LMW PAHs and it is thought that larger PAHs pose more serious health 
hazards (14).  
     It is true that these pollutants do undergo degradation in the environment over time.  
The rate at which this occurs, however, is much slower than the rate at which new PAHs 
are released into the environment.  The Exxon Valdez oil spill of 1989, for instance, 
affected the fate of many organisms.  The pink salmon community in particular showed a 
reduction in egg survival rates for many years.  Contaminants were also transferred by 
tidal cycling and hydraulic gradients to reach developing embryos.  In recent years, 
significant changes in the spawning habitats were seen, which indicated the salmon were 
recovering from the spill (15).  Although this is good news, it is evidence of the 
persistence of PAHs in our environment.  After more than a decade, the effects of this 
major environmental incident have still not completely disappeared.   
     Old PAH contamination is not the only problem to solve.  There are much more recent 
examples of large scale PAH pollution.  The September 11th attacks gave rise to the 
release of 100-1000 tons of PAHs throughout lower Manhattan and beyond.  The highest 
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PAH concentrations were found at the sites closest to the fires.  Those involved in the 
cleanup have been affected greatly.  There have been numerous reports of PAH related 
respiratory illness including, persistent coughs, bronchitis, and new cases of asthma.  It is 
said that these people and others who were exposed have a real risk for lung cancer in the 
future (16).   
      
1.3 Bioremediation  
     Many bioremediation strategies have been developed to clean up PAH contamination.  
Some species of bacteria, fungi and even plants have the ability to degrade these 
pollutants.   
     Although it was believed that eukaryotic organisms could not cleave the fused rings of 
PAHs, Hammel et al. showed the mineralization of phenanthrene by the lignolytic fungus 
Phanerochaete chrysosporium (17).  The white rot fungus Pleurotus ostreatus also 
demonstrated the ability to metabolize phenanthrene (18).   
     Phytoremediation, another bioremediation strategy, involves the use of plants to clean 
up contaminated soil.  Levels of acenaphthalene, anthracene, phenanthrene, naphthalene, 
and fluoranthene all decreased significantly in soils planted with green ash and hybrid 
poplar trees compared to unplanted soils.  There was also an increase in the population of 
microbial degraders in the planted soil versus the unplanted soil (3).  The authors 
suggested the trees increased the rates of PAH degradation through microbial activity in 
the rhizosphere.        
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     Although bacteria in the rhizosphere might assist plants in effectively degrading 
PAHs, they can certainly clean up contaminated soils independently.  Bacteria are well 
known for their adaptation abilities and diverse characteristics.  Many species of bacteria 
are known to degrade PAHs.  Heitkamp and Cerniglia found Mycobacterium PYR-1 can 
degrade fluoranthene, naphthalene and phenanthrene but cannot use these compounds as 
a sole carbon source (19).  Analysis of contaminated soil samples led to the identification 
of three strains of PAH degrading Burkholderia cepacia.  All three isolates degraded 
fluorene, phenanthrene, pyrene, fluoranthene, benz[a,h]anthracene, 
dibenz[a,h]anthracene and benzo[a]pyrene (20).   Krivobok et al. (2) showed  
14C-pyrene mineralization by Mycobacterium sp. strain 6PYI.  An increase in catabolic 
activity and the expression of two ring-cleavage proteins was observed in cells grown on 
pyrene compared to those grown on acetate (2).  Alcaligenes denitrificans strain WW1 
was isolated by Weissenfels et al. (21) and was found to degrade fluoranthene at a rate of 
0.3 mg/ml a day.  Other PAHs, including pyrene and benz[a]anthracene were also 
degraded by strain WW1 via cometabolic processes (21).  Cycloclasticus, an organism 
isolated from marine sediments was able to partially degrade 1 ppm pyrene and 1 ppm 
fluoranthene when 10 ppm phenanthrene was provided in culture (10).  While these 
findings are important, few organisms have been found which can degrade compounds 
with more than three fused benzene rings and additionally can use these compounds as 
sole sources of carbon and energy.     
 
 
 6
1.4 Problems with Bioremediation  
     Although bacteria can breakdown PAHs, this does not mean the PAH pollution 
problem is solved.  In fact, bioremediation through the use of PAH degrading bacteria 
like EPA505 has great potential for PAH cleanup, but there are many unresolved 
problems.  While laboratory experiments can easily demonstrate the ability of these 
organisms to breakdown pollutants, environmental factors may reduce degradation 
abilities in situ.   Some of the factors that affect the efficiency of in situ degradation 
include targeting microbes to the pollutants, soil moisture, oxygen, temperature, pH, 
microbial predation, availability of nutrients, and the production of inhibiting 
metabolites.   
     One major problem with bioremediation has to do with the chemical nature of PAHs.  
Because of hydrophobic interactions, PAHs are sometimes inaccessible to microbial 
degraders in the environment.  Whereas smaller organic compounds might be degraded, 
large PAH molecules are tightly bound to soil particles and as a result accumulate (22).   
     Another problem with bioremediation of PAHs is partial degradation.  Some 
organisms can begin to breakdown the initial compound, but environmental factors may 
inhibit the complete breakdown process.  Partial degradation of PAHs can pose a bigger 
threat as metabolites may be more toxic than parent compounds.  Bouchez et al. (4) 
studied the co-metabolic activity of six bacterial strains grown on several different PAHs.  
Synergistic activity as well as inhibition was noted.  Furthermore, the production of water 
soluble metabolites was found consistently throughout the experiment (4).                       
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If inhibition leads to the accumulation of water soluble intermediate metabolites, the 
result might be contaminated water sources.   
     Some PAHs are partially broken down through abiotic processes such as 
photooxidation.  While this may seem helpful, it can actually lead to a bigger problem.  
Phenanthrene for example, can be converted by sunlight to the more polar product  
9,10-phenanthrenequinone (PheQ).  PheQ can react with biomolecules and, therefore, is 
much more toxic than its parent compound phenanthrene.  The increased toxicity of PheQ 
compared to phenanthrene was demonstrated in bacteria (23) and plants (24).  PheQ was 
also shown to inhibit naphthalene degradation by Burkholderia.  There was a 20% 
degradation of naphthalene in the presence of PheQ as compared to a 75% degradation 
with no PheQ.  The same study showed that a Sphingomonas species could degrade 
PheQ, but only in the presence of phenanthrene (25).   
     Bioremediation problems also exist with S. paucimobilis EPA505.  For example, 
fluoranthene degradation by EPA505 is sometimes inhibited by creosote constitutents.  
An experiment was done to determine which creosote components were actually 
inhibiting the breakdown process.  Creosote compounds were categorized into three 
groups: acidic (phenolics), basic (N-heterocyclics), and neutral (PAHs).  Results 
indicated the inhibitory effects were mostly a result of the basic components in creosote 
(26).  Although the authors found the chemical source of the problem, they did not know 
why there was inhibition.  More information on gene expression and regulation might 
lead to solutions to these types of problems.   
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1.5 Sphingomonads 
     The Sphingomonads refer to organisms belonging to one of four genera including: 
Sphingomonas, Sphingobium, Sphingopyxis, and Novosphingobium.  Members of this 
group are widespread in the environment.  They have been isolated from both aqueous 
and terrestrial habitats as well as clinical specimens and other sources (27).   
     First described by Yabuuchi et al. (1990), the Sphingomonads are Gram-negative, 
chemoheterotrophic, non-spore forming rod-shaped bacteria.  These organisms typically 
produce yellow pigmented colonies.  Some cells may contain a single polar flagellum, 
but others may be non-motile.  One distinctive characteristic of these organisms is that 
they have glycosphingolipids in their cell envelopes instead of the more typical 
lipopolysaccharides (27).  Although there is no evidence to date, it has been suggested 
that these glycosphingolipids may play a role in the successful uptake of PAHs for 
biodegradation (28).   
     Representatives of the genus Sphingomonas seem to have a wider range of substrates 
than other organisms.  For example, Novosphingobium aromaticivorans strain F199 can 
grown on toluene, xylene, p-cresol, biphenyl, naphthalene, dibenzothiophene, fluorene, 
salicylate and benzoate (29,30).  S. yanoikuyae B1 can grown on 1,2,3- trimethylbenzene, 
toluene, p-xylene, biphenyl, naphthalene, phenanthrene and anthracene (31).   
     In addition to a wider range of substrates, certain Sphingomonad species can utilize 
PAHs as a sole carbon and energy source.  For example, whereas many other organisms 
have been shown to degrade two and three-ringed PAHs such as naphthalene, 
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phenanthrene and anthracene, the Sphingomonads can also break down HMW PAHs with 
four and five-rings such as fluoranthene, pyrene, and benzopyrene (32).    
     Sphingomonas  paucimobilis EPA505 was isolated from a seven member community 
from a creosote waste site (33).  It was one of the first organisms reported to degrade and 
use a HMW PAH (fluoranthene) as a sole carbon and energy source (34).  Fluoranthene 
utilization was shown by an increase in cell biomass, disappearance of the HMW PAH, 
and by the production of metabolites.  Additionally, EPA505 cells grown on fluoranthene 
could degrade other compounds such as benzo[b]fluorene, benz[a]anthracene, chrysene, 
and pyrene (34).  Ye et al. (1) studied the degradation activity of fluoranthene grown 
EPA505 cells on other HMW PAHs.  After 16 hours of incubation with 10 ppm of the 
specific compound, S. paucimobilis degraded 80% of pyrene, 72.9% benz[a]anthracene, 
31.5% chrysene, 33.3% benzo[a]pyrene, 12.5% benzo[b]fluoranthene, and 7.8% 
dibenz[a,h]anthracene.  They also found an increase in degradation activity with 
increased cell density.  In addition, cells that were incubated with [7-14C] labeled 
benzo[a]pyrene, and [5, 6, 11, 12-14C] labeled chrysene for 48 hours, degraded 28% of 
the former and 42% of the latter to 14CO2 (1).   
 
1.6 PAH Catabolic Pathway 
     Naphthalene is commonly used as a model compound for PAH degradation studies.  
Although there are some exceptions, the primary pathway for naphthalene degradation is 
divided into an upper and lower catabolic pathway.  For the upper catabolic pathway, 
(Fig. 1.1) the first step occurs when a ring hydroxylating dioxygenase introduces two 
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molecules of oxygen to initiate cleavage of the aromatic ring and form naphthalene cis-
dihydrodiol.  The dihydrodiol product is then dehydrogenated to 1,2-
dihydroxynaphthalene by a cis-naphthalene dihydrodiol dehydrogenase.  The next step 
involves another dioxygenase, namely 1,2-dihydroxynaphthalene dioxygenase which 
yields the product 2-hydroxy-2H-chromene-2-carboxylic acid.  The next two reactions 
are catalyzed by a carboxylate isomerase and a hydratase-aldolase to give 
salicylaldehyde.  This product is converted to salicylate by a dehydrogenase.  In the lower 
catabolic pathway (Fig. 1.2) salicylate is further degraded to TCA cycle intermediates 
either through the catechol or gentisate pathways.  Similar catabolic steps are involved 
for the degradation of phenanthrene, anthracene and other aromatic hydrocarbons.   
 
1.7 Genetics of PAH Degradation in Sphingomonads  
     The genetics of PAH degradation have been studied in some Sphingomonas species.  
The genes involved in aromatic hydrocarbon degradation in this group seem to be highly 
conserved and have been shown to be different from those described in other genera (28).   
     The sequence of a 40kb region from Sphingobium yanoikuyae B1 revealed over 35 
genes on 6 different operons involved in aromatic hydrocarbon degradation.  While at 
least five sets of ring-hydroxylating dioxygenases were found, only one ferredoxin 
reductase (bphA4) and ferredoxin (bphA3) was found among all the genes identified.  
However, these two proteins were found to be associated with multiple dioxygenase 
components (35).  Analysis of the genes in B1 also revealed that the first three enzymes 
in the pathway work on a broad range of substrates and can metabolize naphthalene, 
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phenanthrene and biphenyl.  The nahD gene of B1 encoding the 2-hydroxychromene-2-
carboxylate isomerase, however, was only involved in the degradation of naphthalene 
(35).  Sphingobium yanoikuyae B1 is unusual in that the genes required for the 
degradation of a compound are not arranged on the same operon (28).  
     The complete sequence of a 184-kb catabolic plasmid, pNL1, from Novosphingobium 
aromaticivorans strain F199 has been ascertained (36).   Romine et al. found 79 genes on 
the plasmid that are associated with breakdown or transport of PAHs.  Of the genes 
identified, those that are involved in PAH degradation are in the same order and 
transcriptional direction as the same genes on strain B1.  In addition to the five 
dioxygenase components found in B1, a sixth terminal oxygenase component was 
identified on pNL1 (36).  Genes xylB, nahF, bphD, bphE and bphF were also identified 
on pNL1, but functional analysis has not yet been done (28).   
     In Sphingobium strain P1, transposon mutagenesis interrupted the ferredoxin subunit 
(ahdA4) of a dioxygenase, impairing the ability of the organism to degrade phenanthrene.  
As with strain B1, five sets of terminal oxygenase components were also identified, but 
only one ferredoxin and one ferredoxin reductase were identified.  Additionally, two 
meta-cleavage enzymes bphC and xylE were identified which had 100% identity with 
those genes of strain B1 (37).    
     Recently, the sequence of an aromatic ring-hydroxylating dioxygenases of 
Sphingomonas strain CHY-1 were identified and tested for enzymatic activity.  
Demaneche et al. found the sequence of two genes coding for the alpha and beta subunits 
of a terminal oxygenase, phnA1a and phnA2a (38).  The product of these two genes was 
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collectively called PhnI.  Genes encoding a ferredoxin component (phnA3) and 
ferredoxin reductase component (phnA4) were also identified on separate loci.  All four 
genes were highly similar to genes found in strain F199.  When incubated with several 
different substrates, recombinant PhnI converted PAHs to the respective dihydrodiol 
products.  Furthermore, enzyme activity increased greatly with the co-expression of the 
ferredoxin and ferredoxin reductase subunits (38).   
      Limited work has been done on the genetics of PAH degradation in Sphingomonas 
paucimobilis EPA505.  Tn5 mutants were used to delineate the catabolic pathway of 
EPA505.  Story et al. also found that while a common hydroxylase is involved in the 
pathways for the different substrates studied, EPA505 possesses two distinct hydratase-
aldolase genes.  One is involved in the degradation of naphthalene, phenanthrene and 
anthracene, and the other involved in fluoranthene degradation (40).  It was suggested 
that the genes involved in PAH degradation in strain EPA505 are located on several 
different operons as seen in the other members of this group.   
     Partial gene sequences were obtained for some of the genes involved in the PAH 
catabolic pathway of EPA505 when the regions flanking Tn5 inserts were sequenced.  
Because of its wide range of substrates and ability to grow on some compounds as a sole 
source of carbon, S. paucimobilis EPA505 has great potential for bioremediation.  It is 
therefore necessary to study the genetic basis of degradation in this organism in more 
detail.        
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1.8 Ring-Cleaving Dioxygenases 
     As mentioned earlier, there are several enzymes involved in the PAH upper catabolic 
pathway (Fig 1.1).  The first enzyme in the pathway is a ring-hydroxylating dioxygenase.  
This enzyme initiates the breakdown of the PAH substrate by introducing two oxygen 
molecules into the aromatic ring structure to form a dihydrodiol product.   
     These enzymes are all soluble, multi-component systems that are usually made up of 
two or three separate proteins including: a ferredoxin, a ferredoxin reductase and an iron-
sulfur protein.  The iron-sulfur protein is made up of an alpha and beta subunit and is the 
catalytic oxygenase component (41). The proteins are arranged in a short electron-
transport chain where electrons are moved to the catalytic terminal oxygenase (Fig. 1.3) 
(28). 
     For naphthalene dioxygenase, the reductase component is the first component in the 
electron-transport chain.  Transport is initiated by a single two-electron transfer from 
NAD(P)H to FAD in the ferredoxin reductase which gives the reduced form of FAD.  
The reduced FAD then provides electrons to the ferredoxin.  These electrons are then 
transferred to the iron-sulfur protein or terminal oxygenase which uses the electrons in its 
active site to introduce an oxygen molecule into the aromatic ring (28).  The terminal 
oxygenase component of the chain consists of three alpha and three beta subunits.  These 
subunits come together to form a mushroom like shape with the three alpha subunits 
forming the cap and the three beta subunits forming the stem (52).   
     The substrate specificity of naphthalene dioxygenase has also been investigated.  
Parales et al. showed that the Asp-205 residue in the catalytic domain of naphthalene 
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dioxygenase is necessary for activity.  When site-directed mutagenesis was employed to 
change this residue to either, alanine, glutamate, asparagine or glutamine, mutant proteins 
were not able to transform naphthalene to the dihydrodiol product.  In addition, oxygen 
uptake by the mutant protein was decrease when compared to the wild-type (42).  This 
study confirmed that aspartate was responsible for the successful transfer of electrons to 
the active site.   
     Although S. paucimobilis EPA505 has the ability to break down a wide range of 
substrates and exhibits greater PAH degrading capabilities when compared to other 
organisms, there is limited information on the catabolic enzymes in this organism.  The 
purpose of this work was to identify complete gene sequences encoding PAH degrading 
dioxygenases in EPA505, compare the sequences identified to those in related organisms, 
and carry out functional analysis of the enzymes.  Fundamental knowledge of PAH-
catabolic genes and gene products in this strain may ultimately give way to more efficient 
bioremediation strategies.   
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Table 1.1 US EPA’s 16 priority-pollutant PAHs and selected physical–chemical properties. 
PAH Chemical Structure Molecular weight g/mole 
Solubility 
mg/L 
Naphthalene 
 
128.17 31 
Anthracene 
 
178.23 0.045 
Phenanthrene 
 
178.23 1.1 
Pyrene 
 
202.26 0.132 
Acenaphthene 
 
154.21 3.8 
Acenaphthylene 
 
152.20 16.1 
Flourene 
 
166.22 1.9 
Fluoranthene 
 
202.26 0.26 
Chrysene 
 
228.29 0.0015 
Benzo (a) pyrene 
 
252.32 0.0038 
Benz (a) anthracene 
 
228.29 0.011 
Benzo (k) fluoranthene 
 
252.32 0.0008 
Indeno (1,2,3- cd) pyrene 
 
276.34 0.062 
Benzo (b) fluoranthene 
 
252.32 0.0015 
Dibenzo (a,h) anthracene 
 
278.35 0.0005 
Benzo (g,h,i) perylene 
 
276.34 0.00026 
 16
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Upper catabolic pathway of naphthalene degradation (60). Enzymes: (A) naphthalene 
dioxygenase, (B) cis-naphthalene dihydrodiol dehydrogenase, (C) 1,2-dihydroxynaphthalene dioxygenase, 
(D) 2-hydroxychromene-2-carboxylate isomerase, (E) trans-o-hydroxybenzylidenepyruvate hydratase-
aldolase, (F) salicylaldehyde dehydrogenase. 
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Figure 1.2 Naphthalene lower catabolic pathway.  Salicylic acid created in the upper pathway is further 
metabolized either through the catechol or gentisic acid pathways to TCA cycle intermediates (60).   
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MATERIALS AND METHODS 
 
2.1 Reagents 
     All PAHs, solvents, antibiotics, and derivatizing agents were purchased from Sigma-
Aldrich (St. Louis, MO).  Primers and oligonucleotides were purchased from Integrated 
DNA Technologies (San Diego, CA).  Unless otherwise stated, restriction endonucleases 
and other DNA modification enzymes were purchased from Promega (Madison, WI).   
 
2.2 Bacterial Strains, Plasmids and Growth Conditions 
     Sphingomonas paucimobilis EPA505 was isolated from a creosote waste site (34).  
One colony of S. paucimobilis EPA505 was inoculated into 10 ml of Luria Bertani (LB) 
broth and incubated at 37°C with shaking.  When the culture reached late log phase, 
chloramphenicol was added to a final concentration of 200 µg/ml and the culture was 
incubated further at 37°C with shaking for one hour.  Chloramphenicol was added to 
ensure the genomic DNA collected was from cells in late log phase.  After treatment with 
chloramphenicol, cells were harvested and prepared for library construction.   
     E. coli strains and plasmids used are listed in Table 2.1.  All organisms for 
recombinant DNA experiments were grown in LB media supplemented with the 
appropriate antibiotics.   
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2.3 BAC Library Construction 
     Genomic library construction was carried out at the Clemson University Genomics 
Institute (CUGI).  To construct a BAC (Bacterial Artificial Chromosome) library, high 
molecular weight (HMW) bacterial DNA was first embedded into agarose plugs.  S. 
paucimobilis EPA505 cells were harvested from a late exponential phase culture and 
washed once with 2 ml of NaCl/Tris(pH7.2)/EDTA (200mM NaCl, 10 mM Tris-Cl, 
100mM EDTA)and then resuspended in 0.5 ml of the same buffer.  The cell suspension 
was then placed in a 37°C water bath for 5 minutes.  A solution of 2% (w/v) SeaPlaque 
GTG agarose (FMC BioProducts, Rockland, ME) in water was prepared and equilibrated 
to 40°C in a water bath.  One volume of the agarose solution was mixed with the cell 
suspension, mixed and the solution was poured into plug molds.  After setting, the  plugs 
were removed and placed in a 15 ml screwcap tube and 2-3 volumes of bacterial cell lysis 
solution for HMW DNA (10 mM Tris-Cl, 50 mM NaCl, 100 mM EDTA, 0.2% sodium 
deoxycholate, 0.5% N-lauroylsarcosine, 1mg/ml lysozyme) was added and the mixture 
incubated at 37°C for 2-16 hours.  All BAC library construction procedures after 
preparation of genomic DNA were carried out as previously described (53). 
      
2.4 Overgo Probing of High-Density BAC Membranes 
     Following BAC library construction, high density membranes were made in order to 
probe the library for genes of interest.  Overgo probes were designed from partial PAH 
gene sequences previously obtained from EPA505 (40).  To carry out hybridization, 50 
ml of warm hybridization solution (1% BSA, 1 mM EDTA, 7% SDS, 0.5 M sodium 
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phosphate) was added to a hybridization bottle.  Membranes were pre-moistened with 
warmed 2X SSC and then rolled into a hybridization bottle for a 4-hour prehybridization.  
After prehybridization, about 10 ml of hybridization buffer was removed from the bottle.  
After denaturing the labeled overgos at 90°C for 10 minutes, the probes were added to the 
10ml of buffer and mixed.  The 10 ml was then added back to the bottle with the 
membrane.  Probes were allowed to hybridize overnight in a hybridization oven set at 
60°C with rotation.   
     After hybridization, the buffer was removed and the membrane was washed three 
times.  The membrane was washed first with 1x SSC, 0.1% SDS, second with 1.5x SSC, 
0.1% SDS and once more with 0.75X SSC, 0.1% SDS.  All three washes were carried out 
at 58°C for 30 minutes.  For autoradiography, the filter was sealed in a plastic zip top bag 
and exposed to XAR5 film at 70°C.   
 
2.5 Southern Analysis 
     BAC clones containing genes of interest were digested and analyzed by Southern 
blot/hybridization.  BAC DNA was purified by maxi-prep (43).  Purified DNA was then 
digested at 37°C overnight with HindIII and BamHI (Promega, Madison, WI) and size 
fractionated in a 0.8% (w/v) SeaKem LE agarose gel (BioWhittaker Molecular 
Applications, Rockland, ME) using 1× TAE (40 mM Tris-acetate, 1 mM EDTA, pH 8.0) 
as a running buffer.                                                                                                         
     After separation was completed, the gel was depurinated by incubation in 0.125 N 
HCl followed by a 30 minute incubation in denaturing buffer (1.5 M NaCl, 0.5 M 
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NaOH), and finally a 30 minute incubation in neutralization buffer (1.5 M NaCl, 0.5 M 
Tris pH 7.5).  DNA was transferred to Hybond-XL membrane (Amersham Pharmacia 
Biotech, Little Chalfort, Buckinghamshire, England) by capillary blot using 10× SSC (pH 
7) as a transfer buffer.  Following transfer, DNA was fixed to the membrane by baking at 
80°C for 2 hours.  
     The membrane was prehybridized at 65°C with a 0.5 M sodium phosphate, 7% 
sodium dodecylsulfate (SDS) hybridization buffer for a minimum of 30 minutes. 
Radioactively labeled and denatured DNA probe was added directly to the 
prehybridization solution, and the membrane was hybridized with the probe overnight at 
65°C.  The hybridized membrane was washed at 65°C twice with 2× SSC (pH 7.0), 1% 
(w/v) SDS for 30 minutes, and twice with 1× SSC, 0.1% (w/v) SDS for 30 minutes. The 
membrane was then exposed to autoradiographic film (Kodak X-Omat Blue XB-1, 
Perkin-Elmer Life Sciences, Inc., Boston, MA) overnight.  
   
2.6 Shotgun Library Construction 
     To construct a shotgun library, BAC DNA was purified by maxi-prep (43) and 
subjected to random fragmentation by hydroshearing (Gene Machines, San Carlo, CA). 
 Fragments between 3-5 kb were selected by agarose gel electrophoresis, subjected to 
end-repair/phosphorylation using the End-it end repair kit (Epicentre, Madison, WI), and 
was then cloned into the high copy plasmid pBlueskriptIIKSII+.  Plasmids were then 
electroporated into E. coli DH10B cells. Transformants were selected on LB plates 
containing carbenicillin, X-Gal and IPTG.  White recombinant colonies were picked 
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robotically using the Genetix Q-bot (Genetix, San Jose, CA) and stored as individual 
clones in Genetix 96-well microtiter plates as glycerol stocks at -80°C.  
 
2.7 Primer Design 
     Primer3 software (47) was used to design primers (http://frodo.wi.mit.edu/primer3).  
Genes phnA1a, phnA2a, and phnA3 were found on contigs assembled from high 
throughput sequencing.  To clone these genes, primers were designed to include the 
appropriate restriction sites before and after the start and stop codons of the gene 
sequences.  To locate phnA4, a series of primers were designed based on conserved 
regions of this gene.  Several consecutive rounds of PCR using primer walking and 
04N04 BAC DNA as a template were carried out to eventually obtain the entire phnA4 
gene.   
 
2.8 Sequencing and Analysis 
     Sequencing was carried out at CUGI.  Shotgun clones were sequenced using the 
universal priming sites on the vector.  The data was collected on an ABI 3730xl DNA 
Analyzer (Applied Biosystems, Carlsbad, CA).  For sequencing, 10 ng of DNA for every 
1 kb of sequence and 0.3 µl of 2 µM primer were used.   
     DNA sequence and assembly was carried out using Phred, Phrap, and Consed (44).  
Sequence data was also assembled using Sequencher DNA assembly software (Gene 
Codes Corp, Ann Arbor, MI) and the free BioEdit sequence alignment editor program 
(mbio.ncsu.edu/BioEdit/bioedit.html).  The GenBank tool BLAST at the NCBI server 
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was used to perform similarity searches for genes and proteins (48).  GeneMark free gene 
prediction software (49) was used to search for open reading frames 
(exon.biology.gatech.edu). The ProtParam tool at the Expasy Proteomics Server 
(expasy.org/sprot) was used to determine the size, amino acid sequence and other 
properties of recombinant proteins.  Phylogenetic trees were constructed using MEGA 
software version 4.0 (50) and multiple sequence alignments were carried out with 
ClustalW (51).   
 
2.9 Cloning for Protein Expression 
     For protein expression, genes were cloned into the petDUET-1 and pACYCduet-1 
vectors (Novagen, Madison, WI).  Genes of interest were amplified using 04NO4 BAC 
DNA as a template and KOD Hot Start Polymerase according to the manufacturer’s 
cycling recommendations (Novagen, Madison, WI).  All PCR and gel purification steps 
were carried out using the Wizard SV Gel and PCR Clean-Up System (Promega 
Madison, WI).  
     Compatible Duet expression vectors were kindly provided by Dr. Michael Sehorn of 
Clemson University, Department of Genetics and Biochemistry (Fig. 2.1 and 2.2).  Both 
Duet vectors were provided on agar plates within cultures of E.coli DH5α.  Cells were 
grown overnight in LB broth supplemented with either ampicilin for pETDuet-1 
(50µg/ml) or chloramphenicol for pACYCDuet-1 (34µg/ml).  Plasmid extraction was 
carried out with Qiagen tip-100 and the midi-prep protocol (Qiagen, Valencia, CA).   
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     PCR products were then digested as follows: phnA1a and phnA3 PCR products were 
digested with BamHI and HindIII and were subsequently cloned into the BamHI and 
HindIII sites of petDUET-1 and pACYCduet-1, respectively.  The phnA2a and phnA4 
PCR products were digested with BglII and KpnI and cloned into the second multiple 
cloning sites of petDUET-1 and pACYCduet-1, respectively.  Digested vector was 
dephosphorylated with Thermosensitive Alkaline Phosphatase (Promega, Madison, WI).  
Ligation was carried out with the Ligafast Rapid DNA ligation system (Promega, 
Madison, WI).  Genes phnA1a and phnA2a encoding two oxygenase components were 
cloned into pETDuet-1 to give pD12.  Genes phnA3 and phnA4 encoding the ferredoxin 
and ferredoxin reductase components were cloned into pACYCDuet-1 to yield the 
plasmid pACD34.   
     Transformation was carried out according to the manufacturer’s instructions into 
either E. coli Novablue host cells (Novagen, Madison, WI) for maintenance stocks, or 
into E.coli BL21(DE3) cells for expression of target proteins.  Successful transformation 
and cloning were confirmed with colony PCR using vector specific primers.  
 
2.10 Protein Expression/ SDS-PAGE 
     To express target proteins, BL21(DE3) cells were transformed with either pD12 or 
pACD34 or co-transformed with both plasmids to express all four proteins.  Controls 
were also analyzed in which BL21(DE3) cells were transformed with the original vectors 
pETDuet-1 and/or pACYCDuet-1 containing no insert.  LB broth plus the appropriate 
antibiotic was inoculated with one colony from the BL21(DE3) transformation and 
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incubated overnight at 37°C with shaking.  The overnight culture was used to inoculate a 
secondary culture which was incubated at 37°C with shaking until the OD600 > 0.5.  At 
this point the culture was split in half and IPTG was added to one half at a final 
concentration of 1 mM.  The other half was not induced for comparison.  The induced 
and uninduced cultures were returned to a 37°C incubator with shaking for up to 8 hours 
to analyze protein expression.     
     For SDS-PAGE analysis, cells were harvested and resuspended in phosphate buffered 
saline and 2x SDS loading dye (1:1).  The suspension was then boiled for 5 minutes and 
centrifuged for 1 minute.  Samples were then loaded onto tris-glycine precast gels 
(Biorad, Hercules, CA) with Smart Protein Middle-Range Standard protein marker 
(Genscript, Piscataway, NJ), and run at 120V until the dye front reached the bottom of 
the gel. Gels were visualized with Commassie blue staining (43). 
 
2.11 Assay for Recombinant Protein Activity 
     BL21(DE3)(pD12) expressing the two oxygenase components and 
BL21(DE3)(pD12)(pACD34) expressing two oxygenase and two ferredoxin components 
were tested for enzyme activity.  BL21(DE3)(pETDUET-1) and BL21(DE3)(pETDuet-
1(pACYCDuet-1) harboring the plasmids without inserts were used as controls.  Cells 
were grown in LB broth with appropriate antibiotics to an OD600 > 0.5.                                           
IPTG was then added to a final concentration of 1mM and the culture was incubated at 
25°C overnight with shaking.  Cells were harvested and resuspended in M9 minimal 
medium plus 0.2% glucose at half the original volume so as to double the density of cells 
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in suspension.  In addition, 100 µg of either: naphthalene, phenanthrene or fluoranthene 
dissolved in acetone was added to the cells.  The culture was again incubated at 25°C 
with shaking overnight.  After exposure to the PAHs, cells were harvested and the 
supernatant collected.  The supernatant was extracted twice with ethyl acetate (1:1) and 
dried over sodium sulfate.  Extracts were evaporated using a rotary evaporator and the 
residue was resuspended in 500 µl acetonitrile.  Derivatization was carried out by 
combining 100 µl of the final acetonitrile suspension with 50 µl BSTFA:TMS (99:1) and 
incubated at 65°C for one hour to yield trimethylsilylated products.  Samples were then 
analyzed by GC-MS.  All experiments were done in triplicate.  PAH standards dissolved 
in acetone were run for all substrates tested.   
 
2.12 GC-MS analysis 
      Gas chromatography-mass spectrometry (GC-MS) was performed on an Agilent 7890 
GC and an Agilent 5975 mass spectrometer with triple axis detector (Agilent, Santa 
Clara, CA ).  A J&W DB-5ms capillary column (30m by 0.25mm, 0.25µm film 
thickness) was used for separation of metabolites.  GC-MS analyses were performed as 
follows: the initial oven temperature was set at 80°C and held for two minutes, the 
temperature was then increased at a rate of 8°C per minute until 300°C where it was held 
for 5 minutes.  Electron ionization was achieved at 70eV electron energy and 150°C ion 
source temperature.  Sample injection volumes were 2 µl splitless.  Samples were run in 
scanning mode and the total run time was 34.5 minutes.  Products were identified by 
 28
comparing the data collected to published mass spectra of specific dihydrodiol 
intermediates. 
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Table 2.1 List of bacterial strains and plasmids used in this study. 
 
Bacterial strain or plasmid Relevance/Properties Source/Reference 
 
Strains 
Sphingomonas paucimobilis EPA505 
Escherichia coli DH10B 
Escherichia coli Novablue 
Escherichia coli BL21(DE3) 
 
Plasmids 
pCUGIBAC1 
pBlueskriptIIKSII+ 
pETDuet-1 
pACYCDuet-1 
pD12 
pACD3 
pACD34 
 
 
PAH degrading strain 
genomic library host  
maintenance host for cloned genes  
expression host 
 
 
BAC library vector, Camr 
shotgun library vector, Ampr 
protein expression vector, Ampr 
protein expression vector, Camr 
pETDuet-1 with phnA1a, phnA2a 
pACYCDuet-1 with phnA3 
pACYCDuet-1 with phnA3, phnA4 
 
 
Mueller et al., 1990 
CUGI 
Novagen 
Novagen 
 
 
CUGI 
CUGI 
Novagen 
Novagen 
This study 
This study 
This study 
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Figure 2.1 Vector map of pETDuet-1 plasmid used to clone phnA1a and phnA2a.  Image 
retrieved from www.merck-chemicals.com/life-science-research, September 10th, 2010. 
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Figure 2.2 Vector map of the pACYCDuet-1 plasmid used to clone phnA3 and phnA4.  
Image retrieved from www.merck-chemicals.com/life-science-research, September 10th, 
2010. 
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RESULTS 
 
3.1 BAC Library/Overgo Probing of High Density Filters   
     A BAC library of Sphingomonas paucimobilis EPA505 was constructed at the 
Clemson University Genomics Institute.  Hybridization was carried out using 
oligonucleotide probes designed from partial sequences obtained in previous experiments 
(40).  Following hybridization with the probe designed from a partial dioxygenase, 
numerous positive spots were identified (Fig. 3.1).  A few positive clones were randomly 
picked from the library for further analysis.  
 
Figure 3.1 Overgo probing of high density BAC filters.  Dark dots indicate positive hybridization to 
dioxygenase probe.  Dot pattern indicates the location of the clone in the library.   
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3.2 Southern Analysis of BACs 
     DNA from the selected clones was extracted (Fig. 3.2) and subjected to restriction 
digestion with BamHI and HindIII (Fig. 3.3).  Southern blot analysis revealed potential 
dioxygenase genes in some of the BAC clones.  Because of the strong signal, BAC clone 
#04NO4 was chosen to make a shotgun library (Fig. 3.5).  After this selection process, a 
shotgun library was constructed for high-throughput sequencing.     
 
Figure 3.2 Agarose gel electrophoresis of DNA purified from selected BAC clones.   
 
 
Figure 3.3 Agarose gel electrophoresis of digested BAC clones.  After the marker in the first lane, every 
two lanes represent one BAC clone digested with BamH1 in the first and HindIII in the second lane.   
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Figure 3.4 Southern analysis of digested BAC clones.  Membrane was probed with overgos designed from 
partial dioxygenase gene sequences.  Based on the strong signal, BAC #04N04 was chosen for shotgun 
cloning. 
 
 
3.3 Sequencing Analysis                                                                                                     
     A shotgun library was constructed from one BAC clone which revealed dioxygenase 
genes following Southern analysis.  After construction, the shotgun clones were subjected 
to high throughput sequencing using universal priming sites on the cloning vector.  After 
all sequence data was collected, a total of 15 contigs were assembled.  The results of 
BLAST similarity searches for contigs which revealed putative genes are listed in Table 
3.1.  Several different dioxygenases were identified.  However, only three putative genes 
were selected for further analysis.   
     The first two genes were located on the same contig and showed 99% similarity to the 
phnA1a and phnA2a genes of Sphingomonas CHY-1 (Fig. 3.5).  These two genes encode 
the alpha and beta subunits of an oxygenase.  This contig also contained the aryl alcohol 
dehydrogenase phnB.  A third gene was found on another contig and was 99% similar to 
the bphA3 of Sphingomonas CHY-1.  This gene encodes a ferredoxin and will be referred 
04N04 
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to as phnA3.  The phnA3 gene was found on a contig containing other dioxygenase genes 
which were not selected for further analysis (Fig. 3.6 and Table 3.1).    
 
Figure 3.5 Schematic diagram of the contig containing phnA1a and phnA2a.  The two oxygenase 
components are adjacent to one another and are followed by the aryl alcohol dehydrogenase gene, phnB. 
 
 
 
 
 
 
 
Figure 3.6 Schematic diagram of the contig containing phnA3.  The gene encoding the ferredoxin 
component is preceded by two dioxygenase genes xylX and bph and is followed by genes encoding the 
small (ahdA2c) and large (ahdA1c) subunits of an oxygenase. 
 
 
     According to the literature (38), a fourth gene encoding a ferredoxin reductase subunit 
is necessary to complete the electron transport chain of the ring-hydroxylating 
dioxygenase enzyme.  However, this gene was not identified in the sequencing results of 
the shotgun library.  In order to find this gene, multiple rounds of PCR and sequencing 
were carried out using primers designed from conserved regions of bacterial ferredoxin 
reductase genes and using 04N04 BAC DNA as a template.   After primer walking the 
complete sequence of a fourth subunit was positively identified as it was found to be 
100% similar to the ahdA4 gene of Sphingomonas sp. P2, which encodes a ferredoxin 
reductase.  The ferredoxin reductase subunit of EPA505 found here will be referred to as 
phnA4.  These four genes, i.e. phnA1a, phnA2a, phnA3 and phnA4 encode protein 
products which are components that make up a complete ring-cleaving dioxygenase 
enzyme shown to degrade both high and low molecular weight PAHs (38).   
   xylX           bphC                   bphA3      ahdA2c           ahdA1c 
                                                          (phnA3) 
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      The ProtParam tool at the Expasy Proteomics server was used to determine the 
protein product size for each gene of interest.  The gene encoding the alpha oxygenase 
component, phnA1a, is 1365bp long and was predicted to encode a protein consisting of 
454 amino acids with a molecular weight of approximately 50 kD in size.  PhnA1a 
contains more negatively charged residues than positively charged residues and is 
considered a stable protein with an instability index of 28.12.  The gene encoding the beta 
subunit, phnA2a, is 525bp long.  The protein product for this gene was predicted to be 
174 amino acids long and approximately 21 kD in size.  The amino acid composition for 
PhnA2a shows this protein as having more negatively charged residues.  It also estimates 
an instability index of 47.35, classifying this protein as unstable.  With regard to phnA3, a 
327bp gene, the protein product was estimated to be 11.5 kD and 108 amino acids in 
length.  The amino acid composition shows more negative than positive residues and an 
instability index of 41.16, classifying this protein as unstable.  Lastly, the 1227bp gene 
phnA4 encoding the ferredoxin reductase subunit, was estimated to be 408 amino acids in 
length and 44 kD in size.  The protein product for this gene was estimated to have more 
negatively charged residues and an instability index of 31.05 making this protein stable.   
     Phylogenetic analysis revealed that the PhnA1a and PhnA2a subunits of EPA505 are 
most closely related to the alpha and beta terminal oxygenase components of 
Sphingomonas CHY-1 as was consistent with the BLAST results (Fig 3.18 and 3.19).  
Other closely related terminal oxygenase components include the PhnA1f and PhnA2f of 
Sphingomonas sp. LH128, the ArhA1 and ArhA2 subunits of Sphingomonas sp. A4, and 
the BphA1f and BphA2f subunits of Sphingomonas yanoikuyae B1 (54-56).   
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     A multiple sequence alignment was done to compare the amino acid sequences of the 
alpha and beta subunits of EPA505 to those of related organisms.  When the beta subunit 
PhnA2a was compared to the small subunit of the terminal oxygenase in six other 
organisms, the alignment revealed that some but not most amino acids were conserved 
(Fig. 3.21).  When a multiple sequence alignment was done for PhnA1a, however, many 
residues were conserved among the sequences compared (Fig. 3.20).  Conserved residues 
of significance include the six histidines and two cysteines which are thought to play a 
role in the [2Fe-S] cluster of the alpha subunit (41) and the Asp205 which is believed to 
connect the active site iron center of one alpha subunit to another (57, 58).   
 
3.4 Cloning and protein expression   
     After the complete sequences of these four genes were identified, each gene was 
amplified separately to include appropriate restriction sites for cloning.  Genes phnA1a 
and phnA2a encoding the oxygenase components were cloned into pETDueT-1 to give 
pD12.  Genes phnA3 and phnA4 encoding the ferredoxin components were cloned into 
pACYCDuet-1 to yield the plasmid pACD34.  In addition to these plasmids, expression 
host cells were also transformed with the original vectors containing no insert to yield 
BL21(DE3)(pETDuet-1) and BL21(DE3)(pETDuet-1)(pACYCDuet-1).  These 
transformants were used as controls.   
     BL21(DE3) cells harboring either or both pD12 and pACD34 were grown and 
induced for expression.  When BL21(DE3)(pD12) expressing only the two oxygenase 
components was induced and the cell lysate was analyzed by SDS-PAGE, a 53 kD band 
 38
and a 21 kD band was seen in the induced culture as compared to the uninduced cells.  
These two bands represent the recombinant phnA1a and phnA2a gene products, 
respectively (Fig3.7).  Following induction of BL21(DE3)(pD12)(pACD34) expected to 
express all four subunits, SDS-PAGE analysis revealed two prominent bands at the 
expected sizes of the phnA1a and phnA2a products (Fig3.8).  However, no representative 
bands were seen for the ferredoxin or ferredoxin reductase components.   
 
 
 
Figure 3.7 SDS-PAGE analysis of induced BL21(DE3) cells harboring pD12.  A protein ladder is loaded 
in lane 1.  Odd numbered lanes are induced samples at the various time points following induction with 
IPTG.  Even numbered lanes are the corresponding uninduced samples.    
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Figure 3.8 SDS-PAGE analysis of induced BL21(DE3) cells harboring both pD12 and pACD34.  Protein 
ladder is loaded in lane 1.  Samples in odd numbered lanes are induced and the corresponding uninduced 
samples are loaded in the even numbered lanes.  Two prominent bands can be seen for PhnA1a and 
PhnA2a.  No appropriately sized bands are present for PhnA3 and PhnA4.   
 
Since no bands indicated the expression of the two ferredoxin subunits, pACD3 and 
pACD34 were introduced into the expression host to check expression levels in the 
absence of pD12.  When BL21(DE3)(pACD3) cells carrying the plasmid with the phnA3 
gene only was induced for expression, a band of about 15 kD representing the cloned 
phnA3 gene product was detected by SDS-PAGE.  When BL21(DE3)(pACD34) carrying 
both phnA3 and phnA4 was induced, a 15 kD band indicative of the phnA3 product was 
again seen. However, it was present in a lower concentration than when this gene was 
expressed alone.  Additionally, there was a band below the 50 kD mark.  This was 
presumed to be the 45 kD product of phnA4 (Fig. 3.9).  
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Figure 3.9  SDS-PAGE analysis of BL21(DE3) cells harboring only pACD3 (samples on the left) to 
express phnA3 only, and pACD34  (samples on the right) expressing phnA3 and phnA4.  A protein ladder is 
loaded in lane 1.  Uninduced samples are in lanes 2,4, 7 and 9.  Induced samples are in lanes 3,5,8 and 10.   
 
 
3.5 Assay for Recombinant Protein Activity 
     To test the enzyme activity of the recombinant proteins, all four dioxygenase 
components were expressed by inducing BL21(DE3)(pD12)(pACD34) with IPTG.  The 
induced cells were then incubated with either naphthalene, phenanthrene, or fluoranthene.  
The results of the recombinant protein activity assay are summarized in Table 3.2.   
     When grown in the presence of naphthalene, a product was detected through GC-MS 
with a retention time of 15.73 minutes (Fig. 3.10).  The EI mass spectrum (molecular ion 
at m/z 306) of this product was similar to the mass spectrum found previously for a 
trimethylsilylated naphthalene dihydrodiol production (45) (Fig. 3.11).  In addition, no 
dihydrodiol product was found in the control.   
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     When incubated with phenanthrene, GC-MS also detected a product indicating 
biotransformation of phenanthrene by the dioxygenase with a retention time of 21.67 
minutes (Fig. 3.12).  This product was identified as a phenanthrene dihydrodiol since it 
had the same fragmentation pattern (molecular ion at m/z 356) as the trimethylsilylated 
phenanthrene dihydrodiol previously described (45) (Fig. 3.13).   
      When cells expressing all four components of the dioxygenase were incubated with 
fluoranthene, no breakdown products were detected.  However, unlike with naphthalene 
and phenanthrene, after several hours of incubation, fluoranthene was still detected in the 
supernatant of all cultures including the controls.  This might indicate a problem with 
uptake of fluoranthene. 
     A second assay for fluoranthene was carried out using the cell lysate.  Cells expressing 
all four proteins were induced overnight, harvested, resuspended in Tris buffer (pH 7.5) 
and lysed.  Fluoranthene was then added to the cell lysate.  GC-MS did not detect any 
fluoranthene dihydrodiol products in the lysate samples.                               
     The activity of BL21(DE3)(pD12) expressing only the PhnA1a and PhnA2a 
oxygenase components was also tested.  When these cells were incubated with 
naphthalene, phenanthrene, and fluoranthene, no breakdown products were detected by 
GC-MS.  No fragments were detected to indicate the presence of dihydrodiols for any of 
the substrates tested.    
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Table 3.2 Summarized results of the recombinant protein activity assay for 
BL21(DE3)(pD12)(pACD34) induced cells expressing all four subunits of the          
multi-component dioxygnease.  
 
Expressed 
Proteins 
Compound 
Product 
Identified 
RT 
(min) 
Ionization fragments 
Control Naphthalene ------ 15.73 ----- 
A1aA2aA3A4 Naphthalene 
Naphthalene 
dihydrodiol 
15.73 
73, 147, 191, 203, 275, 
306 
     
Control Phenanthrene ------- 21.67 ----- 
A1aA2aA3A4 Phenanthrene 
Phenanthrene 
dihydrodiol 
21.67 
73, 147, 165,178, 251, 
266, 309, 325, 341, 356 
     
Control Fluoranthene -------- ---- ----- 
A1aA2aA3A4 Fluoranthene -------- ---- ----- 
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Figure 3.10 Extracted ion chromatograms of BL21(DE3)(pD12)(pACD34) and control cultures incubated 
with naphthalene.  (A) A breakdown product was identified with a retention time of 15.73 minutes in cells 
expressing genes for all dioxygenase components.  (B)  No compound was identified in the control at the 
same retention time.  Mass spec data confirmed the compound as a naphthalene dihydrodiol (see Fig 3.11).   
A
B 
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Kim et al., (2005) 
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Figure 3.11 (A) EI mass spectrum of naphthalene dihydrodiol as described by Kim et al., (2005).    
(B) EI mass spectrum of compound identified at 15.73 minutes in BL21(DE3)(pD12)(pACD34) culture 
incubated with naphthalene.  Similar fragmentation patterns positively identified this compound as a 
naphthalene dihydrodiol.   
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Figure 3.12 Extracted ion chromatograms of cultures incubated with phenanthrene.  (A) A compound 
identified at 21.67 minutes in cells expressing all four genes. (B) No compound was identified in the 
control at the same retention time.   
         
B 
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   Kim et al., 2005. 
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Figure 3.13 (A) EI mass spectrum of phenanthrene dihydrodiol (Kim et al., 2005).  (B) EI mass spectrum 
of the compound identified in BL21(DE3)(pD12)(pACD34) phenanthrene culture with a retention time of 
21.67 minutes.  The similar fragmentation pattern confirms this compound as a phenanthrene dihydrodiol.   
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atgagcggcgacaccacactcgtagacactgtcaatgctagccagtcccgtcaggtgttc 
 M  S  G  D  T  T  L  V  D  T  V  N  A  S  Q  S  R  Q  V  F  
tgggacagagacgtttatgatcttgaaatagagcggattttttcccgggcatggttgatg 
 W  D  R  D  V  Y  D  L  E  I  E  R  I  F  S  R  A  W  L  M  
ctcggccacaaatcgcttctcccgaagccgggcgacttcatcacgacttatatggccgag 
 L  G  H  K  S  L  L  P  K  P  G  D  F  I  T  T  Y  M  A  E  
gacaagatcatcctttcgcaccagagcgacgggaccttccgcgcctttatcaattcgtgc 
 D  K  I  I  L  S  H  Q  S  D  G  T  F  R  A  F  I  N  S  C  
acgcaccgcggcaaccagatttgccacgccgacagcggtaacgccaaggcgttcgtctgc 
 T  H  R  G  N  Q  I  C  H  A  D  S  G  N  A  K  A  F  V  C  
aattatcacggctgggtgtacgggcaggatggatcgttggtcgatgtcccactcgagtcg 
 N  Y  H  G  W  V  Y  G  Q  D  G  S  L  V  D  V  P  L  E  S  
cgctgttaccacaacaaactcgataagcaagagctggcggcgaagtctgttcgggtcgaa 
 R  C  Y  H  N  K  L  D  K  Q  E  L  A  A  K  S  V  R  V  E  
acctacaagggtttcattttcggttgccatgatcccgaagcgccaagccttgaagactac 
 T  Y  K  G  F  I  F  G  C  H  D  P  E  A  P  S  L  E  D  Y  
ctgggcgaattccgtttttatctcgacaccatctgggaaggagggggcgctgggctggaa 
 L  G  E  F  R  F  Y  L  D  T  I  W  E  G  G  G  A  G  L  E  
ctgctcggtccgccgatgaagagcctgcttcactgcaactggaaagtgccggtcgaaaat 
 L  L  G  P  P  M  K  S  L  L  H  C  N  W  K  V  P  V  E  N  
tttgtcggcgacggatatcatgtcggatggacccatgcggcggcgcttggtcagatcggt 
 F  V  G  D  G  Y  H  V  G  W  T  H  A  A  A  L  G  Q  I  G  
ggtctgtttgcgggactggccggcaaccgcgcggacattcccttcgacgatcttggattg 
 G  L  F  A  G  L  A  G  N  R  A  D  I  P  F  D  D  L  G  L  
cagttcacgacccggcatggtcatggctttgggttggtcgacaacgcggcggctgcgatc 
 Q  F  T  T  R  H  G  H  G  F  G  L  V  D  N  A  A  A  A  I  
caccgaaagggcgacggctggaacaaatatcttgaggacacccgcggcgaggtgcgccgc 
 H  R  K  G  D  G  W  N  K  Y  L  E  D  T  R  G  E  V  R  R  
aagtttggcgcggatcgcgaacggctttatgtcgggcactggaacggcgcgatcttcccc 
 K  F  G  A  D  R  E  R  L  Y  V  G  H  W  N  G  A  I  F  P  
aattgctcgttcctgtatggcaccaacaccttcaaaatctggcatccacgcgggccgcac 
 N  C  S  F  L  Y  G  T  N  T  F  K  I  W  H  P  R  G  P  H  
gagattgaagtatggacctataccatggtgccgagcgatgccgatcccgctaccaagagt 
 E  I  E  V  W  T  Y  T  M  V  P  S  D  A  D  P  A  T  K  S  
gcgatacagcgcgaagcgacgagaacattcggaaccgccgggacgctggaaagcgacgac 
 A  I  Q  R  E  A  T  R  T  F  G  T  A  G  T  L  E  S  D  D  
ggcgaaaacatgtcttcggcaacctacgtgaaccgtggcgtgatcacgcgtgacggcatg 
 G  E  N  M  S  S  A  T  Y  V  N  R  G  V  I  T  R  D  G  M  
atgaattcgaccatgggcgtcggctacgaaggaccgcatccggtttatcccggaatcgtc 
 M  N  S  T  M  G  V  G  Y  E  G  P  H  P  V  Y  P  G  I  V  
ggcatcagcttcattggcgagacatcctaccggggcttctaccggttctggaaggaaatg 
 G  I  S  F  I  G  E  T  S  Y  R  G  F  Y  R  F  W  K  E  M  
atcgatgcccccgattgggcgagcgtgaaggcaaacgacgacaattgggattcggtcttc 
 I  D  A  P  D  W  A  S  V  K  A  N  D  D  N  W  D  S  V  F  
acgaatcgcaatttctggaacgaaaagctcaacgcggccgaatga 
 T  N  R  N  F  W  N  E  K  L  N  A  A  E  -   
 
Fig. 3.14 Complete phnA1a nucleotide and amino acid sequence 
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atgtcgaccgaacaagttccggtgacgccggatgtgcactacgccgtcgaagcgcactat 
 M  S  T  E  Q  V  P  V  T  P  D  V  H  Y  A  V  E  A  H  Y  
cgtgccgaggtcagactgttgcagaccgggcagtaccgggaatggctgcacggaatggtc 
 R  A  E  V  R  L  L  Q  T  G  Q  Y  R  E  W  L  H  G  M  V  
gccgaagacatccattactggatgccgatttacgaacagcgcttcgtgagagaccggcgc 
 A  E  D  I  H  Y  W  M  P  I  Y  E  Q  R  F  V  R  D  R  R  
ccggacccaacgccagacgatgcggcaatttacaacgacgacttcgaagagctcaagcag 
 P  D  P  T  P  D  D  A  A  I  Y  N  D  D  F  E  E  L  K  Q  
cgtgtcgaacggctttattcaggtcaggtctggatggaggatccgccatccaaaatccgg 
 R  V  E  R  L  Y  S  G  Q  V  W  M  E  D  P  P  S  K  I  R  
tacttcgtgtcgaatgtcgaagcctttgaagccgaaaacggcgaattggacgtcctgtcg 
 Y  F  V  S  N  V  E  A  F  E  A  E  N  G  E  L  D  V  L  S  
aacatccttgtctaccgcaaccgccgccagactgaagtcacggtgcatacattggggcgt 
 N  I  L  V  Y  R  N  R  R  Q  T  E  V  T  V  H  T  L  G  R  
gaagacaagttgcgccaggacggcaatggtttcaaggtcttccggcgaaaacttatcctc 
 E  D  K  L  R  Q  D  G  N  G  F  K  V  F  R  R  K  L  I  L  
gatgcgagagtcacgcaagacaagaatctgtatttcttttgttag 
 D  A  R  V  T  Q  D  K  N  L  Y  F  F  C  -   
 
Fig. 3.15 Complete phnA2a nucleotide and amino acid sequence 
 
 
 
atgtcgaacaaactgcgcctttgccaagtagcggacgttaaggatggtgaacctgtcgcg 
 M  S  N  K  L  R  L  C  Q  V  A  D  V  K  D  G  E  P  V  A  
gtttaccaggagcaaatgcctgcgcttgccgtctacaacgtcgatggcgatgtattcgtc 
 V  Y  Q  E  Q  M  P  A  L  A  V  Y  N  V  D  G  D  V  F  V  
accgacaatatgtgcacccatggcaatgccatgctgaccgatggctaccaggacggcgga 
 T  D  N  M  C  T  H  G  N  A  M  L  T  D  G  Y  Q  D  G  G  
atcatcgaatgcccgttccatggtggttccttcgacatcgccaccggagcagccaaagcc 
 I  I  E  C  P  F  H  G  G  S  F  D  I  A  T  G  A  A  K  A  
tttccctgccaggttccgatcaagacctactcagtcacgatcgacgacggctgggtgtgc 
 F  P  C  Q  V  P  I  K  T  Y  S  V  T  I  D  D  G  W  V  C  
atcgatcagccggaagggagcgcctga 
 I  D  Q  P  E  G  S  A  -   
 
Fig. 3.16 Complete phnA3 nucleotide and amino acid sequence 
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gtgcgctcgattgctatagttggtgcaaacctggccggtgggcgcgcagtcgaagccctg 
 V  R  S  I  A  I  V  G  A  N  L  A  G  G  R  A  V  E  A  L 
cggcaggcagggttcgacgggcggatcaccttgatcggcgaagaaccgtggcgtccttat 
 R  Q  A  G  F  D  G  R  I  T  L  I  G  E  E  P  W  R  P  Y  
gaacggccgccgctctccaaggaagtgctgtgggaaccggcaaatgttccggacaatttc 
 E  R  P  P  L  S  K  E  V  L  W  E  P  A  N  V  P  D  N  F  
ttcctgcaggacgaggcctggtacgacgataaccgtatcgacatgcgcctgggcacccga 
 F  L  Q  D  E  A  W  Y  D  D  N  R  I  D  M  R  L  G  T  R  
gccgaagcaatcgaccttgcgagcggcggggtccgcctgtcagggggcgagctggttcag 
 A  E  A  I  D  L  A  S  G  G  V  R  L  S  G  G  E  L  V  Q  
gcggaccggatcctgctcgccacgggcggtcacgcccgcaagctcaaccttgccggggcc 
 A  D  R  I  L  L  A  T  G  G  H  A  R  K  L  N  L  A  G  A  
gattgcgagaacgtccattatctgcgcacacgagacgatgcgacccgcatggcgctcgac 
 D  C  E  N  V  H  Y  L  R  T  R  D  D  A  T  R  M  A  L  D  
ctgcgcgaaggtgccagcatcgtgatcgtcggcatgggcgtaatcggcgccgaagtcgcc 
 L  R  E  G  A  S  I  V  I  V  G  M  G  V  I  G  A  E  V  A  
gccagtgcggtaaaactcggctgcaaggtcaccgtcgtcgagccgatgccagtgccgatg 
 A  S  A  V  K  L  G  C  K  V  T  V  V  E  P  M  P  V  P  M  
gaaagagcgctcggccggcgctttgggcaatggctgggcgaggagcatcgcaggcgggga 
 E  R  A  L  G  R  R  F  G  Q  W  L  G  E  E  H  R  R  R  G  
gtagcgacccatttcaactgcggcgtgaccggcttcaggtttgccggcaaccgtgtcagc 
 V  A  T  H  F  N  C  G  V  T  G  F  R  F  A  G  N  R  V  S  
gcggtcgtggcagacgatggcaccgtgattccgtgcgatgccgtgatcgtgggggtgggg 
 A  V  V  A  D  D  G  T  V  I  P  C  D  A  V  I  V  G  V  G  
atcgtgccggccacctcgctggcccgcgatgccgggatcgaggtcaacaacgggatcatc 
 I  V  P  A  T  S  L  A  R  D  A  G  I  E  V  N  N  G  I  I  
gtcgaccgtcgatgccagaccagcaacccggcggtattcgcggcgggcgacgtggccgag 
 V  D  R  R  C  Q  T  S  N  P  A  V  F  A  A  G  D  V  A  E  
caggacgggtttttcggcggacggttcaggcaggaaacctaccagaacgctgccgaccag 
 Q  D  G  F  F  G  G  R  F  R  Q  E  T  Y  Q  N  A  A  D  Q  
gcgcaggcgggcgccctggcgatgctggggcaggaggtctcctactgcaagccgatgtgg 
 A  Q  A  G  A  L  A  M  L  G  Q  E  V  S  Y  C  K  P  M  W  
tactggagcgatcagttcgatctcaacatccagttctgcgggcaaattcccgtagaagcc 
 Y  W  S  D  Q  F  D  L  N  I  Q  F  C  G  Q  I  P  V  E  A  
gatatcgcaattcgcggcgagatggacagcaacaccttcgtcgccttcttcctggccggt 
 D  I  A  I  R  G  E  M  D  S  N  T  F  V  A  F  F  L  A  G  
gaaacgatcgaaggcgtactgacggtcaaccgcgcgcccgacatgggggtgggcaagcgg 
 E  T  I  E  G  V  L  T  V  N  R  A  P  D  M  G  V  G  K  R  
ctcgtcgaaaggcgagcccgcgccagcgccgcaagcctggcagacgccaatgtttccttg 
 L  V  E  R  R  A  R  A  S  A  A  S  L  A  D  A  N  V  S  L  
cgggacttgctcaagcaggcgggctga 
 R  D  L  L  K  Q  A  G  - 
 
Fig 3.17 Complete phnA4 nucleotide and corresponding amino acid sequence. Unlike the other subunits, 
PhnA4 starts with a valine. 
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Table 3.1 Significant BLAST search results of contigs assembled after sequencing shotgun clones.     
 
Contig # Database match Organism % Identity Accession no. 
#1 
  1-756bp 
  805-1518bp 
#3 
  1465-2193bp 
#4 
  1-405bp 
  416-970bp 
#5 
  310-1014bp 
#6 
  4-1035bp 
#7 
  320-1288bp 
#8 
  3-407bp 
  469-1152bp 
#9 
  2-862bp 
  1062-1538bp 
  1591-2190bp 
#10 
  71-1324bp 
#11 
  1-1035bp 
#12 
  1079-2444bp 
 
  2488-3013bp 
 
  3059-3083bp 
#13 
  2-550bp 
  550-1044bp 
  1114-2115bp 
  2614-3618bp 
 
#14 
  219-865bp 
 
  1154-2054bp 
 
  2104-2430bp 
 
  2431-2919bp 
  2942-3742bp 
 
#15 
  2667-4349bp 
 
 
Tni-B like transposition protein 
hypothetical protein pCAR_219 
 
plasmid stabilization protein 
 
hydroxythreonine-4-phosphate dehydrogenase  
toluene/benzoate dioxygenase small subunit 
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transposase Tn3 family protein 
 
2-hydroxy-benzylpyruvate aldolase 
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putative methylase/helicase 
 
large subunit of oxygenase 
salicylate 1-hydroxylase beta subunit  
chain A, Sphingomonad Glutathione S-
transferase 
putative partitioning protein ParA 
 
3-isopropylmalate dehydrogenase  
 
alpha subunit, ring-hydroxylating dioxygenase, 
phnA1a 
beta subunit, ring-hydroxylating dioxgenase, 
phnA2a 
partial aryl alchohol dehydrogenase, phnB 
 
large subunit oxygenase 
small subunit oxygenase 
amidohydrolase 2 
demethylmenaquinone methyltransferase 
protein  
 
putative large subunit toluene/benzoate 
dioxygenase, xylX 
putative biphenyl-2,3-diol 1,2-dioxygenase, 
bphC 
putative ferredoxin component of dioxygenase, 
bphA3 
putative small subunit of oxygenase, ahdA2c 
partial putative large subunit of oxygenase, 
ahdA1c 
 
putative cation efflux system  protein 
 
Sphingomonas sp. KA1 
Sphingomonas sp. KA1 
 
Sphingomonas sp. KA1 
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Sphingomonas sp. DN1 
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Sphingomonas sp. CHY-1 
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Sphingomonas sp. CHY-1 
 
Sphingomonas sp. P2 
Sphingomonas sp. P2 
Burkholderia sp. H160 
Ralstonia solanacearum 
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Sphingomonaspaucimobilis 
 
Spingomonas paucimobilis 
 
Spingomonas paucimobilis 
 
Spingomonas paucimobilis 
Spingomonas paucimobilis 
 
 
Pseudomonas aeruginosa 
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YP 718159.1 
YP 718160.1 
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ABM79787.1 
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 AAF72976 Commomonas testosterone
 AAD12610.1 Ralstonia U2
 AAB09766 Burkholderia sp. RASC
 AAD09872 Burkholderia sp.RP007
 BAD34447 Sphingomonas A4
 AAK62353 Burkholderia DBT1
 ACG70971 Acidovorax NA3
 BAC81541 Cycloclasticus A5
 ABW37061 Sphingomonas LH128
 BAB55875 Porphyrobacter sanguineus
 ABM91740 Sphingomonas yanoikuyae B1
 Sphingomonas paucimobilis EPA505
 CAG17576 Sphingomonas CHY-1
 BAG80733 Rhodococcus sp.YK2
 BAA25623.1 Rhodococcus erythropolis
 AAB07750 Rhodococcus sp. M5
 CAA56346 Rhodococcus globerulus
 AAX45786 Pseudomonas putida
 AAC43632 Pseudomonas sp.
 AAC46390 Burkholderia sp.TecA199
100
100
100
99
100
80
100
100
100
93
100
100
100
94
65
96
0.1
 
 
 
 
Fig 3.18 Phylogenetic tree showing the relationship of the alpha subunit PhnA1a and related alpha subunits 
of various organisms. Tree was constructed with MEGA version 4.0. 
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 YP 001268195.1 Pseudomonas putida F1
 CAA06971.1 Ralstonia sp. JS705
 AAC46391.1 Burkholderia sp.
 NP 898769.1 Rhodococcus erythropolis
 1WQL Pseudomonas Fluorescens
 YP 003358095.1 Burkholderia cepacia
 YP 001705092.1 Mycobacterium abscessus
 BAC06603.1 Terrabacter YK3
 BAB55887.1 Terrabacter DBF63
 YP 286445.1 Dechloromonas aromatica
 BAC65447.1 Sphingomonas sp. P2
 AAQ91915.1 Mycobacterium vanbaalenii ...
 AAR05115.1 Rhodococcus P200
 BAC81542.1 Cycloclasticus A5
 NP 049061.1 Novosphingobium aromatici...
 ABW37062.1 Sphingomonas LH128
 2GBW Sphingomonas yanoikuyae B1
 Sphingomonas paucimobilis EPA505
 2CKF Sphingomonas Chy-1
 AAK62354.1 Burkholderia DBT1
 BAE93950.1 Sphingomonas A4
100
77
100
100
99
99
63
98
100
92
99
92
90
39
36
59
29
43
0.1
 
 
 
 
 
Fig. 3.19 Phylogenetic tree showing the relationship of the beta subunit PhnA2a to other known terminal 
oxygenase small subunits.  Tree was constructed using MEGA 4.0.  
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EPA505  MSGDTTLVDTVNASQSRQVFW-DRDVYDLEIERIFSRAWLMLGHKSLLPKPGDFITTYMA 59 
CHY-1   MSGDTTLVDTVNASQSRQVFW-DRDVYDLEIERIFSRAWLMLGHKSLLPKPGDFITTYMA 59 
S.y B1  MSSDATLVDTVNASQSRQVFW-DEDVYALEIERIFSRAWLMLGHESLVPKPGDFITTYMA 59 
S.LH128 MNGSSALVDNAGASQSRRVFW-DQDVYQLELERIFSRCWLMLGHDSLVPKPGDFITTYMA 59 
C.A5    MVDINKLVDTKASTQSKEVFW-DQEVYDREIKNIFGRSWLFLTHECMLEKKGDFITTKMA 59 
S.A4    ---MDDLIDTKRGLQSASMFI-DPHLYEVEMEKIFGRCWLFLTHESAIPNYGDFVTAKMG 56 
P.NDO   MNYNNKILVSESGLSQKHLIHGDEELFQHELKTIFARNWLFLTHDSLIPAPGDYVTAKMG 60 
              :: .  . ..  ::  * .::  *:: **.* **:* *.. :   **::*: *. 
 
EPA505 EDKIILSHQSDGTFRAFINSCTHRGNQICHADSGNAKAFVCNYHGWVYGQDGSLVDVPLE 119 
CHY-1  EDKIILSHQSDGTFRAFINSCTHRGNQICHADSGNAKAFVCNYHGWVYGQDGSLVDVPLE 119 
S.y B1 EDKVILSHQSDGTFRAFINSCSHRGNQICHADSGNAKAFVCNYHGWVFGQDGSLVDVPLE 119 
S.LH128EDRVILSRQPDGSLKAFINSCTHRGNQICHADSGSAKAFVCNYHGWVFGQDGSLVDVPME 119 
C.A5   EDSVIVTRHTDGSLKAFVNSCTHRGNSICSADSGNTKSFVCNYHGWVFSTDGKLVDVPLR 119 
S.A4   EDEVLVVRQEDGTVKAFLNVCRHRGARVCPVEAGNRRAFVCNYHGWSYAADGSLAAIPFE 116 
P.NDO  IDEVIVSRQNDGSIRAFLNVCRHRGKTLVSVEAGNAKGFVCSYHGWGFGSNGELQSVPFE 120 
        * ::: :: **:.:**:* * ***  :  .::*. :.***.**** :. :*.*  :*:. 
 
EPA505 SRCYHNKLDKQELAAKSVR-VETYKGFIFGCHDPEAPSLEDYLGEFRFYLDTIWEGGGAG 178 
CHY-1  SRCYHNKLDKQELAAKSVR-VETYKGFIFGCHDPEAPSLEDYLGEFRFYLDTIWEGGGAG 178 
S.y B1 SRCYHNSLDKQKLAAKSVR-VETYKGFIFGCHDPEAPSLEDYLGEFRYYLDTIWEGAGGG 178 
S.LH128ERCYHSDLDKSKLGLAPIR-VETYKGFIFGCHDPEAPSLEDYLGDFCWYLDTIWDGPDGG 178 
C.A5   EKCYHDELDRDSLSLKTIR-VESYRGFVFGCFDETAPSLEDFLGDWGWYLDTWMVGAGEG 178 
S.A4   KELYGGKIDRCAHGLKEVAKVDSYRGFLFGNFDPGAISLEDYLGDVRWYLDIWMEASG-G 175 
P.NDO  KDLYGESLNKKCLGLKEVARVESFHGFIYGCFDQEAPPLMDYLGDAAWYLEPMFKHSG-G 179 
       .  *  .:::   .   :  *::::**::* .*  * .* *:**:  :**:      . *  
 
EPA505 LELLGPPMKSLLHCNWKVPVENFVGDGYHVGWTHAAALGQIGGLFAGLAGNRADIPFDDL 238 
CHY-1  LELLGPPMKSLLHCNWKVPVENFVGDGYHVGWTHAAALGQIGGPLAGLAGNRADIPFDDL 238 
S.y B1 MELLGPPMKSLLQCNWKVPAENFIGDGYHVGWTHAAALSQIGGELAGLAGNRADIPFDDL 238 
S.LH128LELVGPPLKSTLACNWKVPTENFVGDGYHVGWTHAAALQMIGGELAGLSGNRADMPFDDL 238 
C.A5   AELVGPPMKSILKCNWKVPTENFVGDGYHVGWTHASALHVLGGELGGLAGNQAEMPFDEL 238 
S.A4   VELIGPPARSIVHCNWKAPTENFVGDAYHIGWTHASSLAASRSIFAPMSGN-QMLPPAGA 234 
P.NDO  LELVGPPGKVVIKANWKAPAENFVGDAYHVGWTHASSLRSGESIFSSLAGN-AALPPEGA 238 
        **:*** :  : .***.*.***:**.**:*****::*    . :. ::**   :*     
 
EPA505 GLQFTTRHGHGFGLVDNAAAAIHRKG--DGWNKYLEDTRGEVRRKFGADRERLYVGHWNG 296 
CHY-1  GLQFTTRHGHGFGVIDNAAAAIHRKG--DGWNKYLEDTRGEVRRKFGADRERLYVGHWNG 296 
S.y B1 GLQFTTRHGHGFGVIDNAAAGLHIKR--EGWTKFLEDTRGEVRRKFGPERERLYLGHWNC 296 
S.LH128GLQFTMRHGHGFGLIDNAATAIHVKR--DGYVKYLEQTRGGIREKFGPERERLYVGHWNT 296 
C.A5   GIQVTTRHGHGFGVIDNAAIAIHAKR--DEYAKYMEETIPKVAENLGEPRAKLFNGHWNC 296 
S.A4   GAQIATRFGHGLGILYDVNPGVHTAQTAEKILAWQATKKDKIAEKYGELKARFYGSHLNG 294 
P.NDO  GLQMTSKYGSGMGVLWDGYSGVHSADLVPELMAFGGAKQERLNKEIGDVRARIYRSHLNC 298 
       * *.: :.* *:*:: :   .:*          :   .   : .: *  : ::: .* *  
 
EPA505 AIFPNCSFLYGTNTFKIWHPRGPHEIEVWTYTMVPSDADPATKSAIQREATRTFGTAGTL 356 
CHY-1  AIFPNCSFLYGTNTFKIWHPRGPHEIEVWTYTMVPSDADPATKSAIQREATRTFGTAGTL 356 
S.y B1 SIFPNCSFLYGTNTFKIWHPRGPHEIEVWTYTIVPRDADPATKSMIQREAIRTFGTAGTL 356 
S.LH128SIFPNCSFLYGTNTFKIWHPRGPHEIEVWTYTMVPKNADTETKRSIQREAIRSFGTAGTL 356 
C.A5   STFPNCSFLYGTNIFKVWHPRGPHEIEVWSWVIVHKDMSDEGKREVVKQAVRSFGTAGTL 356 
S.A4   SLFPNVSYLWGTNTLKIWQPRGPSETEVWTWAMAEKDMPEDLKRDIYNGLHGGFGTAGYW 354 
P.NDO  TVFPNNSMLTCSGVFKVWNPIDANTTEVWTYAIVEKDMPEDLKRRLADSVQRTFGPAGFW 358 
       : *** * *  :. :*:*:* ..   ***::.:.  :     *  :       **.**   
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EPA505 ESDDGENMSSATYVNRGVITRDGMMNSTMGVGYEGP-HPVYPGIVGISFIGETSYRGFYR 415 
CHY-1  ESDDGENMSSATYVNRGVITRDGMMNSTMGVGYEGP-HPVYPGIVGISFIGETSYRGFYR 415 
S.y B1 ESDDGENMSSATYINRGVITRNGRMNSTMGVGYEGP-HPVYPGIVGISFIGETSYRGFYR 415 
S.LH128ESDDGENMSSATYNNNGIITRKGRMNSSMGKDREGP-HPVYPGIVGVSFIGETSYRGFYR 415 
C.A5   ESDDGDNMVQSTQVNRGSYTREGEMNSTMGQGYEGE-HPDYPGIVGSSFIGETSYRGFYR 415 
S.A4   EADDNDNMESASLLPTGWQSRKLRLNAQMGIGNDTVMDEM-PGVIGQAAIGETSYRGYYR 413 
P.NDO  ESDDNDNMETASQNGKKYQSRDSDLLSNLGFGEDVYGDAVYPGVVGKSAIGETSYRGFYR 418 
       *:**.:**  ::       :*.  : : :* . :   .   **::* : ********:** 
 
EPA505    FWKEMIDAPDWASVKANDDNWDSVFTNRNFWNEKLNAAE------ 454 
CHY-1     FWKEMIDAPDWASVKANDDNWDSVFTNRNFWNEKLNAAE------ 454 
S.y B1    FWKEMIDAPDWASVKANDDTWDSVFPNRNFWNEKLNAAE------ 454 
S.LH128   FWQEILDAPDWAAIRANDDTWDAMWTNRNFWPERLSAKQAEPQD- 459 
C.A5      FYQEMMSADSWDDIRANDEHWADCFPNKNYWkDRIAAKAAEAEGE 460 
S.A4      FYDEILKLPSWDAFDLNDEGWKQQLID----ADR----------- 443 
P.NDO     AYQAHVSSSNWAEFEHASSTWHTELTKT---TDR----------- 449 
           :.  :.  .*  .   .. *     .     ::        
 
Fig 3.20 Multiple sequence alignment of PhnA1a (alpha subunit of the terminal oxygenase component) 
with the alpha subunits of Sphingomonas sp. CHY-1 (CHY-1), Sphingobium yanoikuyae B1 (S. y B1), 
Sphingomonas sp. LH128 (S.LH128), Cycloclasticus sp. A4, Sphingomonas sp. A4, and the naphthalene 
dioxygenase alpha subunit of Pseudomonas .  Fully conserved amino acid residues are indicated by an 
asterisk.  Five conserved histidines and two conserved cysteines are highlighted in yellow. The conserved 
Asp205 is highlighted in gray.  Regions highlighted in red are hypothesized to be responsible for the ability 
to breakdown large substrates (Leu223, Leu226, Ile253 and Ile260 of CHY-1) (52).  Alignment was 
constructed with ClustalW.   
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EPA     ----------------MSTEQVPVTPDVHYAVEAHYRAEVRLLQTGQYREWLHGMVAEDI 44 
CHY-1   ----------------MSTEQVPVTPDVHYAVEAHYRAEVRLLQTGQYREWLHGMVAEDI 44 
S.y B1  ----------------MSSEQIPVTPDVHYDIEAHYRAEVRMFQTGQYREWLQGMVAEDI 44 
S.LH12  ----------------MTETRKPVGMELHHAIVSHYSAEVRMLQNQQYRQWFDTVIAEDI 44 
C.A5    --------------MHNTEAKERVSSELHYELSQHYYQEATLLQNGEFNTWIETFVAKDL 46 
Psuedo  -------MTSADLTKPIEWPEMPVSLELQNAVEQFYYREAQLLDYQNYEAWLA-LLTQDI 52 
S.A     MENANQIVKTMGADVWDGDPELIADHDLLHRVQAFTNREARLLDTGRVREWLDEMIHPDI 60 
                            .  .  ::   :  .   *. :::  . . *:  .:  *: 
 
EPA    HYWMPIYEQRFVRDRRPDPTP-DDAAIYNDDFEELKQRVERLYSGQVWMEDPPSKIRYFV 103 
CH     HYWMPIYEQRFVRDRRPDPTP-DDAAIYNDDFEELKQRVERLYSGQVWMEDPPSKIRYFV 103 
S.y B1 HYWMPIYEQRLTRDRRPDPTP-DDAAIYNDDFGELKQRVERLYSGQVWMEDPPSKIRYFV 103 
S.LH128HYRMPVYEQRFARDRRPDPTP-GDAAIYNDDYAELQQRVDRLLTGQVWMEDPPSRIRYFV 103 
C.A5   HYWMPVTERRYAKDKRPEPTP-YDMAIYNDDYDEVKDRVARLLTGAVWMEDPRSTVRYLI 105 
Pseudo QYWMPIRTTHTSRNKAMEYVPPGGNAHFDETYESMRARIRARVSGLNWTEDPPSRSRHIV 112 
S.A4   RYVIISRQLRYIEERR--YLPPDSVFIYDDDHGVLNARVEQQLHPQNWRINPREAYVRIG 118 
       :* :     :  .::     *  .   ::: .  :. *:        *  :* .    :  
 
EPA    SNVEAFEAE-NGELDVLSNILVYRNRRQTEVTVHTLGREDKLRQDGN--GFKVFRRKLIL 160 
CHY-1  SNVEAFEAE-NGELDVLSNILVYRNRRQTEVTVHTLGREDKLRQDGN--GFKVFRRKLIL 160 
S.y B1 SNVEAFEAG-NGELDVLSNILVYRNRRQTEVTVHTLGREDKLRRDGN--GFKVFRRKLIL 160 
S.LH128TNVEAFEIA-PFEFEVFSNVLVHRNRRQSEVYVHTLGREDKLRKTDS--GFKVFSRKLNI 160 
C.A5   TNIEAFHTDKDDEFVVRSNFVVYRHRGQLEHSEHVGCRQDLIRKVGN--GFQLARRKVSL 163 
Pseudo SNVIVRETESAGTLEVSSAFLCYRNRLERMTDIYVGERRDILLRVSDGLGFKIAKRTILL 172 
S.A4   TNLEVTKGSAKDRLFVRTNWHLRRMRRQYQIDDFIYSRHDELVITPDQ-GFKFVKRFIAF 177 
       :*: . .      : * :     * * :     .   *.* :    .  **:.  * : : 
 
EPA    DARVTQDKNLYFFC 174 
CHY-1  DARVTQDKNLYFFC 174 
S.y B1 DARVTQDKNLYFFC 174 
S.LH128DARVVQDKNLYFFA 174 
C.A5   DARVTEDKNLYIFF 177 
Pseudo DQSTITANNLSQFF 186 
S.A4   AERGVQGRNMTLFL 191 
              .*:  *  
 
Fig 3.21 Multiple sequence alignment of PhnA2 (beta subunit of the terminal oxygenase component) with 
the beta subunit of Sphingomonas sp. CHY-1 (CHY-1), Sphingobium yanoikuyae B1, Sphingomonas sp. 
LH128 (S.LH128), Cycloclasticus sp. A5 (C.A5), Pseudomonas fluorescens(Pseudo), and Sphingomonas 
sp. A4 (S.A4).  Conserved residues are indicated by asterisks.   
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DISCUSSION 
      
     Members of the genus Sphingomonas are known for their abilities to breakdown a 
wider range of PAH substrates compared to other PAH degrading bacteria (40).  Because 
of their potential for bioremediation, it is necessary to study these organisms in more 
detail to understand the breakdown process at the molecular level.  Many enzymes are 
involved in the PAH breakdown process.  The first enzyme in the pathway is always a 
ring-hydroxylating dioxygenase (28).  Dioxygenases are of particular importance since 
they initiate the pathway by breaking the aromatic ring of the hydrocarbon.  
Dioxygenases are multi-component enzymes usually consisting of oxygenase 
components and a ferredoxin and/or a ferredoxin reductase (41). 
     Sphingomonas paucimobilis EPA505 was isolated from a seven member community 
at a creosote waste site (34).  This organism was able to degrade high molecular weight 
PAHs and even demonstrated an ability to use one PAH as a sole carbon source.  After 
constructing a BAC library, oligonucleotide probes were designed specifically to target 
dioxygenase genes.  After selecting BAC clones that hybridized to the probe, a shotgun 
library was constructed to carry out high throughput sequencing.   
     Sequencing shotgun clones revealed many putative genes (Table 3.1).  From the 
sequencing data assembled, S. paucimobilis EPA505 appears to have many different 
dioxygenases.  This is not surprising as other Sphingomonads have been shown to have 
genes encoding more than one dioxygenase.   
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     Multiple dioxygenase genes were identified and phnA1a, phnA2a, and phnA3 were 
chosen for further analysis.  These three genes encode three subunits of a dioxygenase.  
All together these proteins were expected to form a dioxygenase complex which could 
breakdown both high and low molecular weight PAHs.  The three genes encode an alpha 
and beta oxygenase component, and a ferredoxin component respectively.  According to 
Demaneche et al. (38), a fourth gene encoding a ferredoxin reductase subunit was also 
necessary for optimal activity.  However this gene was not identified in the assembled 
sequences of this study.  Multiple rounds of PCR and sequencing were carried out to 
eventually obtain the entire sequence of a gene which was 100% similar to the ahdA4 
gene of Spingomonas sp. P2.  This gene encodes a ferredoxin reductase and was named 
phnA4 for this study.     
     Phylogenetic analysis of the PhnA1a and PhnA2a subunits showed similarity of these 
terminal oxygenase components to many other naphthalene dioxygenase like enzymes in 
various organisms (Fig. 3.18 and 3.19).  A multiple sequence alignment revealed some 
amino acid conservation in the beta subunit, but much more conservation among the 
alpha subunits (Fig. 3.20 and 3.21).  All alpha subunits aligned showed five conserved 
histidine and two conserved cysteine residues which are believed to be critical for protein 
function.  The Asp205 residue was also conserved among all enzymes.  This amino acid 
is thought to directly connect the active iron center of one alpha subunit to the 
neighboring unit as the main route for electron transfer (58).   
     All four genes were cloned for expression.  BL21(DE3) host cells expressing the 
oxygenase components only as well as cells expressing all four components were 
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induced.  When BL21(DE3)(pD12) cells harboring the plasmid to express PhnA1a and 
PhnA2a oxgenase subunits were induced with IPTG, a 53 kD and 21 kD protein was 
detected by SDS-PAGE (Fig 3.7).  These two bands indicated the successful expression 
of the phnA1a and phnA2a genes since they were present only in the induced samples.   
     When BL21(DE3) cells harboring the plasmids pD12 and pACD34 were induced for 
expression, the only bands detected by SDS-PAGE were representative of the phnA1a 
and phnA2a genes of pD12 (Fig 3.9).  No expression was seen for either ferredoxin 
component (phnA3, phnA4) cloned on the pACD34 plasmid.  Unsuccessful expression 
could be attributed the plasmid copy number.  Plasmid pD12 carrying the genes phnA1a 
and phnA2a, was derived from pETDuet-1.  This vector has an estimated copy number of 
40.  Plasmid pACD34 carrying the two genes encoding the ferredoxin components, 
namely phnA3 and phnA4, was derived from pACYCDuet-1.  This vector has an 
estimated copy number of 10.  Because the latter has a much lower copy number, and 
because copy number probably decreases as genes are cloned into the vector, the amount 
of expression subsequently decreased.  This might explain why expression of the genes 
cloned into the vector with the higher copy number was only visible with SDS-PAGE.   
     Another explanation could be that there was a problem in the construction of the 
plasmids for expression.  Sequencing was carried out to confirm genes were in frame 
after cloning.  However, to be sure that the lack of expression was not an issue with the 
vector, pACD34 was introduced into BL21(DE3) cells to check for expression in the 
absence of pD12.  BL21(DE3) cells were also transformed with pACD3 which only 
harbored the phnA3 gene.  After induction of BL21(DE3)(pACD3), an appropriately 
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sized band of 15 kD was observed with SDS-PAGE indicating successful expression of 
PhnA3.  After inducing BL21(DE3)(pACD34), a 15 kD band and another band below the 
50 kD mark were observed.  The band below the 50 kD mark was assumed to be the 45 
kD ferredoxin reductase component as it was only present in the induced samples.  In 
addition, the 15 kD size band representing the phnA3 gene product was lower in 
concentration compared to when this gene was expressed alone.  This was another 
indication that both genes were being expressed.   
     The successful expression of the phnA3 and phnA4 genes in the absence of pD12 
confirmed that there was no problem with the expression vector or the construct.  The 
lack of expression seen was probably due to the low copy number.  When cells harboring 
both plasmids are induced to express all four subunits, the ferredoxin components were 
most likely being expressed.  However, expression was at such a low level that these 
proteins were not being detected by SDS-PAGE.   
     Enzyme activity of the recombinant proteins was examined.  To look for dioxygenase 
activity, BL21(DE3)(pACD34)  and BL21(DE3)(pD12) cells were both tested for the 
ability to transform PAHs into their corresponding dihydrodiol products.      
     Demaneche et al. observed enzyme activity, albeit minimal, when the oxygenase 
components of Sphingomonas CHY-1 were expressed in the presence of PAHs.  When 
cells expressing only the PhnA1a and PhnA2a proteins of CHY-1 were incubated with 
various PAHs, dihydrodiol products were detected (38).  Although the activity was much 
lower than the activity observed by cells carrying all four subunits, the two oxygenase 
components were able to transform the PAHs without the ferredoxin components.  To test 
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this for EPA505’s dioxygenase, BL21(DE3)(pD12) cells harboring the plasmid to 
express only the PhnA1a and PhnA2a products were grown in the presence of PAHs.  
However, unlike experiments with CHY-1, no dihydrodiol product was detected by    
GC-MS.        
     When BL21(DE3)(pD12)(pACD34) was incubated with naphthalene, a product with 
the GC-MS characteristics of a naphthalene dihydrodiol was detected.  The EI mass 
spectrum of this product was compared to the previously described mass spectra of 
naphthalene dihydrodiol formed by Mycobacterium vanbaalenii (45).  The similarities 
between the mass spectra obtained in this study and that of Kim et al. (45) confirmed the 
presence of naphthalene dihydrodiol.   
     When cells expressing the complete dioxygenase were incubated with phenanthrene, 
the presence of a phenanthrene dihydrodiol was confirmed by comparing the mass 
spectra obtained to that of Kim et al. (45).  The fragmentation patterns observed for the 
products detected confirm the presence of dihydrodiols.  These dihydrodiols are evidence 
of dioxygenase activity and show the ability of these recombinant proteins to work 
together to transform the PAH substrates into corresponding breakdown products.         
     BL21(DE3)(pD12)(pACD34) cells expressing all four subunits of the dioxygenase 
were able to break down naphthalene and phenanthrene into corresponding dihydrodiols, 
whereas cells expressing only the oxygenase components showed no dioxygenase 
activity.  The difference in activity supports the idea that the ferredoxin components were 
being expressed even though they were not detected by SDS-PAGE.   
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     It appears that in EPA505, all four components are necessary for dioxygenase activity.  
However, the enzyme activity is being analyzed with recombinant proteins.  This might 
have an effect on the stability of the proteins in the cell, as compared to when they are 
produced naturally by EPA505.  Considering the similarity between the phnA1a and 
phnA2a genes of EPA505 and those in Sphingomonas CHY-1, it is difficult to believe 
that their protein products do not have some ability to transform PAHs without the 
ferredoxin components.  It is also possible that some of the other dioxygenases identified 
may show PAH degrading activity without the ferredoxin components.  Until all factors 
are taken into account, and all assay conditions are tested, it cannot be said with certainty 
that all four components are absolutely required for activity.   
     When the enzyme was exposed to the HMW PAH, fluoranthene, no breakdown 
products were observed in the whole cell assay or the assay using cell lysate.  The lack of 
activity with the whole cell assay could be attributed to an inability of the BL21(DE3) 
cells to take up the fluoranthene.  This host does not secrete overexpressed proteins into 
the media.  Therefore, the only way for the proteins and the substrate to interact would be 
for the substrate to enter the cell.  When the whole cell assay was carried out for 
naphthalene and phenanthrene, dihydrodiol products were identified.  More importantly, 
there was little or none of the original substrate in the supernatant of the cells expressing 
the enzyme as well as the control cells.  The lack of the original substrate, even in the 
control cells where no breakdown products were detected, is probably an indication that 
the PAH is entering the cell where it can come in contact with the enzyme.  With the 
fluoranthene experiments, however, no dihydrodiol products were identified and unlike 
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the other substrates, fluoranthene remained in the supernatant.  Since fluoranthene is a 
larger compound than naphthalene and phenanthrene, it is possible that this substrate is 
not entering the cell as easily and is not coming in contact with the enzyme.  This may be 
one reason why fluoranthene was not broken down as expected.   
     To ensure contact between the enzyme and fluoranthene, another activity assay was 
carried out using the cell lysate.  Once again, no dihydrodiol products were identified.  
However, the lack of activity against fluoranthene does not rule out the ability of this 
enzyme to break down HMW PAHs.  Even though fluoranthene was not broken down, 
this could be due to instability on the part of the enzyme.  After induction, cells were 
resuspended in a simple Tris buffer and lysed.  This lysate was then used to test activity 
against fluoranthene.  It is possible that the buffering conditions were not optimal and the 
recombinant proteins were not stable after cell lysis.  If this assay is repeated, the cell 
lysate should also be tested against naphthalene and phenanthrene as controls since the 
enzyme was shown to degrade these compounds.     
     There is a possibility that the substrate range of the PhnI protein in EPA505 is just not 
the same as other dioxygenases.  BLAST similarity search results indicate the terminal 
oxygenase components of EPA505 are 99% similar to those of Sphingomonas CHY-1.  
However, CHY-1 was shown to have great versatility in breaking down both low and 
high molecular weight PAHs.  When the crystal structure of the PAH degrading 
dioxygenase of CHY-1 was determined by Jakoncic et al. (52), the authors found that the 
catalytic pocket of the enzyme from CHY-1 is at least 2A ̊ longer, wider and higher at the 
entrance when compared to other ring-hydroxylating dioxygenases.  This larger pocket 
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was attributed to the amino acids Leu223, Leu226, Ile253, and Ile260.  The multiple sequence 
alignment indicates that EPA505’s alpha subunit only contains the Leu226 and the Ile260.  
This may be a reason why EPA505 was unable to breakdown fluoranthene.  Although 
PhnA1a of EPA505 shares such high similarity with the PhnA1 of CHY-1, the 
differences in these amino acid residues may account for EPA505’s inability to 
breakdown larger substrates.   
     Sphingomonas paucimobilis EPA505 has great potential as a tool for bioremediation.  
In this study, a multi-component dioxygenase was identified and tested for activity 
against different PAHs.  To our knowledge this is the first report of functional analysis of 
dioxygenase from EPA505. Future studies will include a more detailed analysis of this 
enzyme as well as the other dioxygenases identified.  Testing enzyme activity in different 
environments in order to find out optimal activity conditions as well as conditions which 
inhibit activity may eventually lead to better bioremediation strategies.   
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